Search - tctmd.com

Displaying 341 - 360 of 1120

Sort: Relevancy | Date

Presentation TCT 2016

Valve-in-Valve Therapies - Not Just a Russian Doll! Technical and Clinical Challenges: Clinical Updates

Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Danny Dvir

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research III: Updates From Italian Registries and OBSERVANT

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Corrado Tamburino

October 30, 2016

Presentation TCT 2016

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure)

Presenter: A. Pieter Kappetein, Allan Schwartz, Samir R. Kapadia

October 30, 2016

Presentation TCT 2016

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? Stop Wasting Valuable Time Go Straight to LVAD/Transplant!

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Nir Uriel

October 30, 2016

Presentation TCT 2016

Valve-in-Valve Therapies - Not Just a Russian Doll! Technical and Clinical Challenges: Engineering Perspectives

Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Ajit Yoganathan

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research II: Updates From the UK TAVR Registry

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Neil E. Moat

October 30, 2016

Presentation TCT 2016

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? MitraClip Should Always Be Considered First!

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Saibal Kar

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research I: Updates From GARY and Other German Registries

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Thomas Walther

October 30, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat

Presenter: A. Pieter Kappetein, Allan Schwartz, James B. Hermiller Jr.

October 30, 2016

Presentation TCT 2016

Debate #1: Should Low bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? Yes As Long As Full Consent Is Provided, Let the Patient Decide!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, David Hildick-Smith

October 30, 2016

Presentation TCT 2016

Update on RCTs in FMR, and First Report of the COAPT Roll-in Patients

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Gregg W. Stone

October 30, 2016

Presentation TCT 2016

Paravalvular Regurgitation - The Achilles Hell or Problem Solved: Better Assessment of PVL on the Bench - Recommendations by the ISO Cardiac Valves Committee

Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Neelakantan Saikrishnan

October 30, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip)

Presenter: A. Pieter Kappetein, Allan Schwartz, Marco Barbanti

October 30, 2016

Presentation TCT 2016

Debate #1: Should Low Bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? No Chronic Anticoagulation Should be Offered First

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Stefan C. Bertog

October 30, 2016

Presentation TCT 2016

Complications After MitraClip: Frequency, Avoidance, and Treatment

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Scott Lim

October 30, 2016

Presentation TCT 2016

Paravalvular Regurgitation - The Achilles Heel or Problem Solved: Latest Updates on the Assessment of Paravalvular Regurgitation (Aortic and Mitral)

Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Rebecca T. Hahn

October 30, 2016

Presentation TCT 2016

Techniques to Achieve >1+ MR After MitraClip: How Often Is This Obtainable?

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Saibal Kar

October 30, 2016

Presentation TCT 2016

Symptomatic High-Risk Aortic Regurgitation: Is TAVR A Viable Alternative?

Presenter: A. Pieter Kappetein, Allan Schwartz, Hendrik Treede

October 30, 2016

Presentation TCT 2016

Pushing the Anatomic Envelope of MitraClip Eligibility: What Are the Limits?

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Hüseyin Ince

October 30, 2016

Advertisement

Valve-in-Valve Therapies - Not Just a Russian Doll! Technical and Clinical Challenges: Clinical Updates

Key Contributions to TAVR Clinical Research III: Updates From Italian Registries and OBSERVANT

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First!

Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure)

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? Stop Wasting Valuable Time Go Straight to LVAD/Transplant!

Valve-in-Valve Therapies - Not Just a Russian Doll! Technical and Clinical Challenges: Engineering Perspectives

Key Contributions to TAVR Clinical Research II: Updates From the UK TAVR Registry

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? MitraClip Should Always Be Considered First!

Key Contributions to TAVR Clinical Research I: Updates From GARY and Other German Registries

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat

Debate #1: Should Low bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? Yes As Long As Full Consent Is Provided, Let the Patient Decide!

Update on RCTs in FMR, and First Report of the COAPT Roll-in Patients

Paravalvular Regurgitation - The Achilles Hell or Problem Solved: Better Assessment of PVL on the Bench - Recommendations by the ISO Cardiac Valves Committee

Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip)

Debate #1: Should Low Bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? No Chronic Anticoagulation Should be Offered First

Complications After MitraClip: Frequency, Avoidance, and Treatment

Paravalvular Regurgitation - The Achilles Heel or Problem Solved: Latest Updates on the Assessment of Paravalvular Regurgitation (Aortic and Mitral)

Techniques to Achieve >1+ MR After MitraClip: How Often Is This Obtainable?

Symptomatic High-Risk Aortic Regurgitation: Is TAVR A Viable Alternative?

Pushing the Anatomic Envelope of MitraClip Eligibility: What Are the Limits?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content